Imetelstat: a first-in-class telomerase inhibitor

A unique molecule targeting a hallmark of cancer

Updated privacy policy

We encourage you to read our updated privacy policy, available here. To view the prior version of our privacy policy, click here.

A transformative approach

Disease-modifying potential in hematologic malignancies

Together we can make a difference in patients’ lives

Partnerships are key to our success

A visionary history

Creating a legacy of bold innovation